Pancreatic Cancer Research

ResearcherThe University of MelbourneNo recent work listed

Christopher Christophi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1349-0884; OpenAlex author ID A5034893498. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper

Papers 4

  1. Serum carbohydrate antigen 19-9 in pancreatic adenocarcinoma: a mini review for surgeons. Co-author DOI 10.1111/ans.14131↗
  2. Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases. Co-author DOI 10.1016/j.canlet.2014.01.001↗
  3. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Co-author DOI 10.1245/s10434-014-3625-6↗
  4. Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma. Last author DOI 10.3109/08941939.2013.797057↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mehrdad Nikfarjam · 3 shared papers, 2013–2014 · strength 0.14
  2. Vijayaragavan Muralidharan · 1 shared paper, 2017 · strength 0.10
  3. Su Kah Goh · 1 shared paper, 2017 · strength 0.10
  4. Dannel Yeo · 2 shared papers, 2013–2014 · strength 0.08
  5. Hong Zhen He · 2 shared papers, 2013–2014 · strength 0.08
  6. Pikli Batabyal · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.